Phase 4
N=60
Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture
Pain
Bottom Line
View on ClinicalTrials.gov: NCT01719237 ↗Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Onset of Surgical Anesthesia — 16; 22; 9; 16 minutes
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Ropivacine and Chloroprocaine mixture (Drug); Ropivacaine only (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Nov 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Onset of Surgical Anesthesia |
16; 22; 9; 16; 6; 10 | — |
| SECONDARY Duration of Analgesia |
566; 718 | — |
Summary
A double blinded randomized controlled trial comparing the onset and duration of the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using a long acting local anesthestic (Ropivacaine) with a mixture of a long and short acting local anesthestic (Ropivacaine-Chloroprocaine Mixture).
Eligibility Criteria
Inclusion Criteria
- Patients who will be having a supraclavicular brachial plexus block as part of their anesthetic will be approached for possible inclusion in the study
Exclusion Criteria
- patients who are pregnant,
- have an ASA status of IV or greater,
- neuropathy,
- a cast or other impediment to performing a motor or sensory exam in the arm and hand,
- patients under the age of 18,
- long term opioid therapy (longer than 1 month),
- history of opioid abuse and pseudocholinesterase deficiency
Data sourced from ClinicalTrials.gov (NCT01719237). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.